CUUR Diagnostics was founded by experienced medical scientists and healthcare professionals to utilize industry leading equipment including the latest technologies from ThermoFisher; are staffed by a premier team of licensed, experienced scientists and laboratory technicians; and have up to date protocols conducted in modern state-of-the-art laboratories. We operate under the CAP and CLIA quality standards and have received Emergency Use Authorization (EUA) by the U.S. FDA.
Early detection is possible by molecular assay as it detects the viral nucleic acid or virus, which can detect as early as exposure – meaning before infection has initiated in the body. According to the CDC symptoms may appear 2-14 days after exposure making early detection an important tool in the fight against the Coronavirus Pandemic.
Advancing Molecular Infectious Disease Care Continuum